GGGuangcan Gao
Guangcan Gao
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Guangcan Gao has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
A. Xiong
Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai/CN
1 shared publicationB. Chen
Shanghai Pulmonary Hospital, Tongji University, Shanghai/CN
1 shared publication- Chengbei Zhou
Shanghai Pulmonary Hospital, Shanghai/CN
1 shared publication - Chunxia Su
Department of Comprehensive Oncology Center, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China
1 shared publication - Fei Zhou
Department of Medical Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
1 shared publication - Feng Wu
Guangdong Polytechnic Normal University
1 shared publication
Latest Publications
- Open Access
- 29 October 2023
- Published by Elsevier in International Immunopharmacology
- Vol. 125 (Pt A) , 111125
Single-cell RNA sequencing in double-hit lymphoma: IMPDH2 induces the progression of lymphoma by activating the PI3K/AKT/mTOR signaling pathway
- 29 October 2023
- Published by Elsevier in International Immunopharmacology
- Vol. 125 (Pt A) , 111125
Open AccessSingle-cell RNA sequencing in double-hit lymphoma: IMPDH2 induces the progression of lymphoma by activating the PI3K/AKT/mTOR signaling pathway
- 1 October 2019
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 14 (10) , S383
P1.01-62 Association of Baseline Pulmonary Fibrosis with the Outcome of PD-1 Inhibitor in Patients with Advanced Non-Small Cell Lung Cancer
- 1 October 2019
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 14 (10) , S383
P1.01-62 Association of Baseline Pulmonary Fibrosis with the Outcome of PD-1 Inhibitor in Patients with Advanced Non-Small Cell Lung Cancer